Literature DB >> 9614573

Drug inducible transgene expression in brain using a herpes simplex virus vector.

T Oligino1, P L Poliani, Y Wang, S Y Tsai, B W O'Malley, D J Fink, J C Glorioso.   

Abstract

The ability to regulate transgene expression is likely to be important in the use of gene transfer to treat diseases of the central nervous system (CNS). In order to achieve regulatable gene expression we created a replication-incompetent genomic herpes simplex vector containing a RU486-inducible transactivator and a lacZ reporter gene under transcriptional control of a minimal promoter. Reporter gene expression from the vector was regulated by administration of RU486 in vitro and in vivo. In cell culture half maximal expression was achieved with 10(-8) M RU486, and maximal expression was achieved by 24 h. Following stereotactic inoculation of the vector into rat hippocampus, expression was increased 150-fold by i.p. administration of RU486. This demonstrates that the RU486 system functions as a tight on/off switch for regulating expression of a transgene delivered to the brain via an HSV vector.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9614573     DOI: 10.1038/sj.gt.3300612

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  5 in total

Review 1.  Regulatable systems: applications in gene therapy and replicating viruses.

Authors:  S Agha-Mohammadi; M T Lotze
Journal:  J Clin Invest       Date:  2000-05       Impact factor: 14.808

Review 2.  HSV-1-based vectors for gene therapy of neurological diseases and brain tumors: part II. Vector systems and applications.

Authors:  A Jacobs; X O Breakefield; C Fraefel
Journal:  Neoplasia       Date:  1999-11       Impact factor: 5.715

3.  The Impact of Mouse Preterm Birth Induction by RU-486 on Microglial Activation and Subsequent Hypomyelination.

Authors:  Cécile Morin; David Guenoun; Irvin Sautet; Valérie Faivre; Zsolt Csaba; Leslie Schwendimann; Pierrette Young-Ten; Juliette Van Steenwinckel; Pierre Gressens; Cindy Bokobza
Journal:  Int J Mol Sci       Date:  2022-04-27       Impact factor: 6.208

4.  Gene regulation systems for gene therapy applications in the central nervous system.

Authors:  Jerusha Naidoo; Deborah Young
Journal:  Neurol Res Int       Date:  2012-01-05

5.  In-Depth Characterization of a Mifepristone-Regulated Expression System for AAV5-Mediated Gene Therapy in the Liver.

Authors:  Jolanda M Liefhebber; Raygene Martier; Tom Van der Zon; Sonay Keskin; Angelina Huseinovic; Jacek Lubelski; Bas Blits; Harald Petry; Pavlina Konstantinova
Journal:  Mol Ther Methods Clin Dev       Date:  2019-05-16       Impact factor: 6.698

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.